CYP1A1 polymorphisms and risk of prostate cancer. A meta-analysis

Urology Journal

Volumn 6, Issue 2, 2009, Pages 78-86

  Shaik, Abjal Pasha ^a   Jamil, Kaiser ^b   Das, Prabhavathy ^b  

^a Indo American Cancer Institute and Research Centre   (India)

^b Bhagwan Mahavir Medical Research Centre   (India)

Author keywords

CYP1A1; Genetic polymorphisms; Meta analysis; Prostatic neoplasms

Indexed keywords

CYTOCHROME P450 1A1;

AGE DISTRIBUTION; AGED; ARTICLE; CONFIDENCE INTERVAL; GENE EXPRESSION REGULATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HUMAN; INCIDENCE; MALE; META ANALYSIS; MIDDLE AGED; PATHOPHYSIOLOGY; PROSTATE TUMOR; RISK; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SURVIVAL;

AGE DISTRIBUTION; AGED; CONFIDENCE INTERVALS; CYTOCHROME P-450 CYP1A1; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; PROSTATIC NEOPLASMS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS;

EID: 66549097871     PISSN: 17351308     EISSN: 1735546X     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Kawajiri K. Cyp1a1. IARC Sci Publ. 1999;(148):159-72.
2. Haas GP, Sakr WA. Epidemiology of prostate cancer. CA Cancer J Clin. 1997;47:273-87.
3. Masson LF, Sharp L, Cotton SC, Little J. Cytochrome P-450 1A1 gene polymorphisms and risk of breast cancer: a HuGE review. Am J Epidemiol. 2005;161:901-15.
4. Latil AG, Azzouzi R, Cancel GS, et al. Prostate carcinoma risk and allelic variants of genes involved in androgen biosynthesis and metabolism pathways. Cancer. 2001;92:1130-7.
5. Berthon P, Valeri A, Cohen-Akenine A, et al. Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43. Am J Hum Genet. 1998;62:1416-24.
6. Ingles SA, Ross RK, Yu MC, et al. Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J Natl Cancer Inst. 1997;89:166-70.
7. Monroe KR, Yu MC, Kolonel LN, et al. Evidence of an X-linked or recessive genetic component to prostate cancer risk. Nat Med. 1995;1:827-9.
8. Hildebrandt AG, Schwarz D, Krusekopf S, Kleeberg U, Roots I. Recalling P446. P4501A1 (CYP1A1) opting for clinical application. Drug Metab Rev. 2007;39:323-41.
9. Gao JP, Huang YD, Yang GZ, Yang YQ. [Relationship between genetic polymorphisms of metabolizing enzymes and prostate cancer]. Zhonghua Nan Ke Xue. 2003;9:32-5. Chinese.
10. Narod SA, Dupont A, Cusan L, et al. The impact of family history on early detection of prostate cancer. Nat Med. 1995;1:99-101.
11. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. CA Cancer J Clin. 2001;51:15-36.
12. Berndt SI, Chatterjee N, Huang WY, et al. Variant in sex hormone-binding globulin gene and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 2007;16:165-8.
13. Smith G, Stubbins MJ, Harries LW, Wolf CR. Molecular genetics of the human cytochrome P450 monooxygenase superfamily. Xenobiotica. 1998;28:1129-65.
14. Potosky AL, Miller BA, Albertsen PC, Kramer BS. The role of increasing detection in the rising incidence of prostate cancer. JAMA. 1995;273:548-52.
15. Chang BL, Zheng SL, Isaacs SD, et al. Polymorphisms in the CYP1A1 gene are associated with prostate cancer risk. Int J Cancer. 2003;106:375-8.
16. Cunningham JM, Hebbring SJ, McDonnell SK, et al. Evaluation of genetic variations in the androgen and estrogen metabolic pathways as risk factors for sporadic and familial prostate cancer. Cancer Epidemiol Biomarkers Prev. 2007;16:969-78.
17. Nock NL, Liu X, Cicek MS, et al. Polymorphisms in polycyclic aromatic hydrocarbon metabolism and conjugation genes, interactions with smoking and prostate cancer risk. Cancer Epidemiol Biomarkers Prev. 2006;15:756-61.
18. Beer TM, Evans AJ, Hough KM, Lowe BA, McWilliams JE, Henner WD. Polymorphisms of GSTP1 and related genes and prostate cancer risk. Prostate Cancer Prostatic Dis. 2002;5:22-7.
19. Aktas D, Hascicek M, Sozen S, Ozen H, Tuncbilek E. CYP1A1 and GSTM1 polymorphic genotypes in patients with prostate cancer in a Turkish population. Cancer Genet Cytogenet. 2004;154:81-5.
20. Mittal RD, Srivastava DL. Cytochrome P4501A1 and microsomal epoxide hydrolase gene polymorphisms: gene-environment interaction and risk of prostate cancer. DNA Cell Biol. 2007;26:791-8.
21. Li M, Guan TY, Li Y, Na YQ. Polymorphisms of GSTM1 and CYP1A1 genes and their genetic susceptibility to prostate cancer in Chinese men. Chin Med J (Engl). 2008;121:305-8.
22. Yang J, Qian LX, Wu HF, et al. Genetic polymorphisms in the cytochrome P450 1A1 and 2E1 genes, smoking, drinking and prostate cancer susceptibility: a case-control study in a Han nationality population in Southern China. Int J Urol. 2006;13:773-80.
23. Silig Y, Pinarbasi H, Gunes S, Ayan S, Bagci H, Cetinkaya O. Polymorphisms of CYP1A1, GSTM1, GSTT1, and prostate cancer risk in Turkish population. Cancer Invest. 2006;24:41-5.
24. Suzuki K, Matsui H, Nakazato H, et al. Association of the genetic polymorphism in cytochrome P450 (CYP) 1A1 with risk of familial prostate cancer in a Japanese population: a case-control study. Cancer Lett. 2003;195:177-83.
25. Acevedo C, Opazo JL, Huidobro C, Cabezas J, Iturrieta J, Quinones Sepulveda L. Positive correlation between single or combined genotypes of CYP1A1 and GSTM1 in relation to prostate cancer in Chilean people. Prostate. 2003;57:111-7.
26. Caceres DD, Iturrieta J, Acevedo C, Huidobro C, Varela N, Quinones L. Relationship among metabolizing genes, smoking and alcohol used as modifier factors on prostate cancer risk: exploring some gene-gene and gene-environment interactions. Eur J Epidemiol. 2005;20:79-88.
27. Figer A, Friedman T, Manguoglu AE, et al. Analysis of polymorphic patterns in candidate genes in Israeli patients with prostate cancer. Isr Med Assoc J. 2003;5:741-5.
28. Murata M, Shiraishi T, Fukutome K, et al. Cytochrome P4501A1 and glutathione S-transferase M1 genotypes as risk factors for prostate cancer in Japan. Jpn J Clin Oncol. 1998;28:657-60.
29. Vijayalakshmi K, Vettriselvi V, Krishnan M, Shroff S, Jayanth VR, Paul SF. Cytochrome p4501A1 gene variants as susceptibility marker for prostate cancer. Cancer Biomark. 2005;1:251-8.
30. Guan TY, Li M, Na YQ. [Polymorphism of metabolic gene and genetic susceptibility to prostate cancer]. Zhonghua Wai Ke Za Zhi. 2005;43:1467-70. Chinese.
31. Nock NL, Tang D, Rundle A, et al. Associations between smoking, polymorphisms in polycyclic aromatic hydrocarbon (PAH) metabolism and conjugation genes and PAH-DNA adducts in prostate tumors differ by race. Cancer Epidemiol Biomarkers Prev. 2007;16:1236-45.
32. Murata M, Watanabe M, Yamanaka M, et al. Genetic polymorphisms in cytochrome P450 (CYP) 1A1, CYP1A2, CYP2E1, glutathione S-transferase (GST) M1 and GSTT1 and susceptibility to prostate cancer in the Japanese population. Cancer Lett. 2001;165:171-7.